These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
380 related articles for article (PubMed ID: 26527155)
1. miRNAs as Circulating Biomarkers for Alzheimer's Disease and Parkinson's Disease. Mushtaq G; Greig NH; Anwar F; Zamzami MA; Choudhry H; Shaik MM; Tamargo IA; Kamal MA Med Chem; 2016; 12(3):217-25. PubMed ID: 26527155 [TBL] [Abstract][Full Text] [Related]
2. An overview of circulating cell-free microRNAs as putative biomarkers in Alzheimer's and Parkinson's Diseases. Batistela MS; Josviak ND; Sulzbach CD; de Souza RL Int J Neurosci; 2017 Jun; 127(6):547-558. PubMed ID: 27381850 [TBL] [Abstract][Full Text] [Related]
3. Profiles of extracellular miRNA in cerebrospinal fluid and serum from patients with Alzheimer's and Parkinson's diseases correlate with disease status and features of pathology. Burgos K; Malenica I; Metpally R; Courtright A; Rakela B; Beach T; Shill H; Adler C; Sabbagh M; Villa S; Tembe W; Craig D; Van Keuren-Jensen K PLoS One; 2014; 9(5):e94839. PubMed ID: 24797360 [TBL] [Abstract][Full Text] [Related]
4. Specific Signatures of Serum miRNAs as Potential Biomarkers to Discriminate Clinically Similar Neurodegenerative and Vascular-Related Diseases. Barbagallo C; Mostile G; Baglieri G; Giunta F; Luca A; Raciti L; Zappia M; Purrello M; Ragusa M; Nicoletti A Cell Mol Neurobiol; 2020 May; 40(4):531-546. PubMed ID: 31691877 [TBL] [Abstract][Full Text] [Related]
5. Morphometric and Nanomechanical Screening of Peripheral Blood Cells with Atomic Force Microscopy for Label-Free Assessment of Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral Sclerosis. Taneva SG; Todinova S; Andreeva T Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762599 [TBL] [Abstract][Full Text] [Related]
6. miRNAs as biomarkers of neurodegenerative disorders. Viswambharan V; Thanseem I; Vasu MM; Poovathinal SA; Anitha A Biomark Med; 2017 Feb; 11(2):151-167. PubMed ID: 28125293 [TBL] [Abstract][Full Text] [Related]
7. Several miRNAs derived from serum extracellular vesicles are potential biomarkers for early diagnosis and progression of Parkinson's disease. He S; Huang L; Shao C; Nie T; Xia L; Cui B; Lu F; Zhu L; Chen B; Yang Q Transl Neurodegener; 2021 Jul; 10(1):25. PubMed ID: 34315539 [TBL] [Abstract][Full Text] [Related]
8. Ultrasensitive detection of blood biomarkers of Alzheimer's and Parkinson's diseases: a systematic review. Singh K; Cheung BM; Xu A Biomark Med; 2021 Dec; 15(17):1693-1708. PubMed ID: 34743546 [No Abstract] [Full Text] [Related]
10. Blood serum miRNA: non-invasive biomarkers for Alzheimer's disease. Geekiyanage H; Jicha GA; Nelson PT; Chan C Exp Neurol; 2012 Jun; 235(2):491-6. PubMed ID: 22155483 [TBL] [Abstract][Full Text] [Related]
11. Oligomeric α-synuclein and β-amyloid variants as potential biomarkers for Parkinson's and Alzheimer's diseases. Williams SM; Schulz P; Sierks MR Eur J Neurosci; 2016 Jan; 43(1):3-16. PubMed ID: 26332448 [TBL] [Abstract][Full Text] [Related]
12. Recent developments in circulating biomarkers in Parkinson's disease: the potential use of miRNAs in a clinical setting. Teixeira Dos Santos MC; Bell R; da Costa AN Bioanalysis; 2016 Dec; 8(23):2497-2518. PubMed ID: 27855513 [TBL] [Abstract][Full Text] [Related]
13. Tiny But Mighty: Promising Roles of MicroRNAs in the Diagnosis and Treatment of Parkinson's Disease. Wang Y; Yang Z; Le W Neurosci Bull; 2017 Oct; 33(5):543-551. PubMed ID: 28762215 [TBL] [Abstract][Full Text] [Related]
14. Circulating miRNAs as biomarkers for neurodegenerative disorders. Grasso M; Piscopo P; Confaloni A; Denti MA Molecules; 2014 May; 19(5):6891-910. PubMed ID: 24858274 [TBL] [Abstract][Full Text] [Related]
15. The Immune System and Neuroinflammation as Potential Sources of Blood-Based Biomarkers for Alzheimer's Disease, Parkinson's Disease, and Huntington's Disease. Clark LF; Kodadek T ACS Chem Neurosci; 2016 May; 7(5):520-7. PubMed ID: 27046268 [TBL] [Abstract][Full Text] [Related]
16. Plasma neuronal exosomes serve as biomarkers of cognitive impairment in HIV infection and Alzheimer's disease. Pulliam L; Sun B; Mustapic M; Chawla S; Kapogiannis D J Neurovirol; 2019 Oct; 25(5):702-709. PubMed ID: 30610738 [TBL] [Abstract][Full Text] [Related]
17. A panel of four decreased serum microRNAs as a novel biomarker for early Parkinson's disease. Dong H; Wang C; Lu S; Yu C; Huang L; Feng W; Xu H; Chen X; Zen K; Yan Q; Liu W; Zhang C; Zhang CY Biomarkers; 2016; 21(2):129-37. PubMed ID: 26631297 [TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein E4 serum concentration for increased sensitivity and specificity of diagnosis of drug treated Alzheimer's disease patients vs. drug treated parkinson's disease patients vs. age-matched normal controls. Goldknopf IL; Park HR; Sabbagh M Curr Alzheimer Res; 2012 Dec; 9(10):1149-67. PubMed ID: 22950864 [TBL] [Abstract][Full Text] [Related]
19. Circulatory miR-223-3p Discriminates Between Parkinson's and Alzheimer's Patients. Mancuso R; Agostini S; Hernis A; Zanzottera M; Bianchi A; Clerici M Sci Rep; 2019 Jun; 9(1):9393. PubMed ID: 31253822 [TBL] [Abstract][Full Text] [Related]